A Multi-Center, Double-Blind, Randomized, Placebo-Controlled, Parallel Group Trial, Investigating the Efficacy and Safety of Repeated Lamazym Treatment of Subjects With Alpha-Mannosidosis.
Phase of Trial: Phase III
Latest Information Update: 04 Apr 2017
Price : $35 *
At a glance
- Drugs Velmanase alfa (Primary)
- Indications Alpha-Mannosidosis
- Focus Registrational; Therapeutic Use
- Sponsors Zymenex A/S
- 09 Feb 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 20 May 2014 New trial record